Interestingly , a combinatorial immunotherapy of anti - HER - 2 / neu antibody with AdV HER - 2 vaccine was capable of curing 4 of 10 studied mice bearing well - established Tg1 - 1 breast tumors and significantly delaying in death of the remaining six tumor - bearing mice ( Po0 . 05 ) .